Clinical pharmacology of the neuromuscular junction in myasthenia gravis. (Preliminary communication)
Jurenić, D.; Jusić, A.
Neurologija 26(1-4): 37-39
1978
ISSN/ISBN: 0350-9559 PMID: 754038 Document Number: 127564
Document emailed within 1 workday
Related Documents
Matsumoto, R.; Motomura, M.; Yoshimura, T.; Kohara, N.; Kato, T. 1999: Myasthenia gravis with electrophysiological features of Lambert-Eaton myasthenic syndrome: usefulness of serum autoantibodies assay and neuromuscular junction biopsy Rinsho Shinkeigaku 39(5): 531-537Pozaniakov, O.M.; Babakova, L.L.; Kolomenskaia, E.A.; Kuz'min, N.V. 1975: Ultrastructure of the neuromuscular junction in myasthenia Arkhiv Patologii 37(10): 55-63
Bufler, J. 2010: Neuromuscular disease--myasthenia gravis MMW Fortschritte der Medizin 151(Suppl 4): 153-158
Pirskanen, R. 1979: Myasthenia gravis and other neuromuscular diseases Duodecim; Laaketieteellinen Aikakauskirja 95(21): 1401-1411
Pirskanen-Matell, R.; Matell, G.; Kalb, B.; Bjelak, S. 2000: Myasthenia gravis--an autoimmune neuromuscular disease Lakartidningen 97(41): 4594-4598
De Léan, J. 1983: Effects of plasmapheresis on neuromuscular transmission in myasthenia gravis L'Union Medicale du Canada 112(1): 9-13
Pühringer, F.K.; Rex, C.; Renner, M.; Kazmaier, F. 2001: Undiagnosed myasthenia gravis unmasked by neuromuscular blockade British Journal of Anaesthesia 87(4): 650-651
Nogués, M.A.; Rivero, A.; Stalberg, E. 1991: Single fiber electromyogram in myasthenia gravis and other neuromuscular diseases Medicina 51(4): 307-314
Hohlfeld, R. 1990: Myasthenia gravis and thymoma: paraneoplastic failure of neuromuscular transmission Laboratory Investigation; a Journal of Technical Methods and Pathology 62(3): 241-243
Marsh, D.O. 1974: Adrenal therapy for neuromuscular disease including myasthenia gravis from 1896 New York State Journal of Medicine 74(11): 1974-1976
Monsalve Naharro, J.A.; Gerónimo Pardo, M.; Ortiz Sánchez, V.E.; Pérez Valdivieso, J.M. 2011: Sugammadex reversal of neuromuscular blockade for thymectomy in a patient with myasthenia gravis Revista Espanola de Anestesiologia y Reanimacion 58(10): 624-625
Tsujihata, M.; Hazama, R.; Ishii, N.; Ide, Y.; Takamori, M. 1979: Ultrastructural localization of the acetylcholine receptor in myasthenia gravis and in related neuromuscular diseases Rinsho Shinkeigaku 19(11): 751-759
Shibuya, N. 1978: A serum factor blocking neuromuscular transmission in myasthenia gravis: electrophysiological study with intracellular microelectrodes Rinsho Shinkeigaku 18(4): 177-184
Szobor, A. 1989: Myasthenia gravis: familial occurrence. A study of 1100 myasthenia gravis patients Acta Medica Hungarica 46(1): 13-21
el-Zunni, S.; Prakash, P.S.; Saitti, M.; Busnaina, I.A. 1996: Myasthenia gravis (MG): a preliminary report Central African Journal of Medicine 42(3): 77-80
Vincent, A.; Newsom-Davis, J. 1982: Acetylcholine receptor antibody characteristics in myasthenia gravis. II. Patients with penicillamine-induced myasthenia or idiopathic myasthenia of recent onset Clinical and Experimental Immunology 49(2): 266-272
Saha, S.P.; Mukherjee, S.; Das, S.K.; Ganguly, P.K.; Roy, T.N.; Maiti, B.; Bhattacharya, S.; Sarkar, S. 1998: Clinical profile of myasthenia gravis Journal of the Association of Physicians of India 46(11): 933-936
Masaoka, A.; Maeda, M.; Monden, Y.; Nakahara, K.; Kotake, Y. 1976: Clinical results following thymectomy in myasthenia gravis Medical Journal of Osaka University 26(3-4): 117-129
De Crousaz, G. 1979: Myasthenia gravis: clinical studies of 50 patients Revue Medicale de la Suisse Romande 99(5): 277-283
Sri-udomkajorn, S.; Panichai, P.; Liumsuwan, S. 2011: Childhood myasthenia gravis: clinical features and outcomes Journal of the Medical Association of Thailand 94(Suppl 3): S152-S157